AmBisome Monotherapy and Combination AmBisome-Miltefosine Therapy for the Treatment of Visceral Leishmaniasis in Patients Coinfected With Human Immunodeficiency Virus in India: A Randomized Open-Label, Parallel-Arm, Phase 3 Trial.
Sakib BurzaRaman MahajanShahwar KazmiNeal AlexanderDeepak KumarVikash KumarEstrella LasryAmit HarshanaAlan de Lima PereiraPradeep DasNeena VermaVidya Nand Ravi DasChandra Shekhar LalBharat RewariVishal GoyalSuman RijalFabiana AlvesNaresh GillKrishna PandeyPublished in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America (2022)
Clinical Trial Registry India (CTRI/2015/05/005807; the protocol is available online at https://osf.io/avz7r).
Keyphrases
- human immunodeficiency virus
- open label
- clinical trial
- end stage renal disease
- hepatitis c virus
- antiretroviral therapy
- phase ii
- newly diagnosed
- ejection fraction
- chronic kidney disease
- hiv infected
- combination therapy
- prognostic factors
- phase iii
- healthcare
- peritoneal dialysis
- phase ii study
- hiv aids
- patient reported outcomes
- health information
- double blind
- rectal cancer
- patient reported
- placebo controlled